Healthcare

Rep. Stefanik says ‘we are seeing the chipping away of our civil liberties’ over vaccine requirements

Published

2 years ago

August 9, 2021

By Jenny Goldsberry

“Every American should be outraged we are seeing chipping away of civil liberties across the country,” Stefanik said. “And New York City unfortunately is ground zero for this.”
Rep. Elise Stefanik

Rep. Elise Stefanik (R-NY) lashed out at Democrats in New York for the “chipping away of civil liberties.” Lately, New Yorkers need to reveal their vaccination status to enter to bars, gyms, concerts or even schools. Meanwhile, the vaccination rate across the state is relatively high. Stefanik talked about how vaccination requirements are affecting New Yorkers on Fox News Sunday.

“Every American should be outraged we are seeing chipping away of civil liberties across the country,” Stefanik said. “And New York City unfortunately is ground zero for this.”

After Governor Cuomo hosted a press release asking businesses to enforce vaccination requirements, business owners took on a new, executive role. “Now our restaurant owners are becoming law enforcement officers and having to make tough decisions as individuals are coming in with vaccine cards. Some of them are counterfeit cards,” Stefanik said. “This is not the rule of restaurants and we should not have policies that segregate those who have been vaccinated or not vaccinated.”

Concerned Parents

Meanwhile, the GOP Conference Chair says that most constituents are actually concerned parents, who want to know the state of public education. “We all want to make sure our kids get back to school in person but there’s already discussion about a mask mandate which is not based upon science,” Stefanik said. “We know that our kids, few are affected by COVID.”

Stefanik vouched for parents in the midst of a sexist scandal of her own. Vermont’s Channel 3 News blasted the New York representative for daring to serve in office while pregnant. A guest on the show Monday accused her of “not being at full energy” because of her pregnancy.

Thank you @kayleighmcenany, @HARRISFAULKNER, and @OutnumberedFNC for highlighting the sexist coverage from @wcax and for setting an example for all working moms across America.

Yes, you can have it all. pic.twitter.com/MKfZUZAzbB
— Rep. Elise Stefanik (@RepStefanik) August 9, 2021

However Stefanik disputed the comments in a tweet saying: “yes, you can have it all.” She also said she is grateful to be “setting an example for all working moms across America.”

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

2 days ago

June 7, 2023

Sara Carter Staff

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4

— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.